An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Related Posts
Tasting the Humors?
The ancient Greeks are regarded as the founders of modern medicine. However, their belief that illness was a punishment and that health and healing were…
Apple Launches AirPods Pro 2 Hearing Aid
On September 9, Apple announced that it is entering the over-the-counter (OTC) hearing aids market. The company will soon offer an AirPods Pro 2 hearing…
Mahomes and the Vestibular System
During a recent practice session, the Kansas City Chiefs Super Bowl winning quarterback, Patrick Mahomes, tested out his passing ability while blindfolded and dizzy. Mahomes…